Collectively, our studies support the cognitive enhancement effects of miR-23b-3p, identify the miR-23b-3p-elicited GSK-3β/p-tau/Bax/caspase-3 pathway as a promising network-based target, and investigate novel compounds based on miR-23b-3p interference for AD. The gene discussed is BAX; the disease is Alzheimer disease.